AstraZeneca LP Loses Canada Court Case Over Generic Nexium

Reuters -- Generic competition to AstraZeneca's (AZN.L) top-selling acid reflux drug Nexium moved a step closer in Canada, after a court rejected the drugmaker's bid to stop a copycat version from entering the market.